# Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

> **NCT07267819** · — · RECRUITING · sponsor: **Uniformed Services University of the Health Sciences** · enrollment: 60 (estimated)

## Conditions studied

- Migraine
- Traumatic Brain Injury
- Anomalous Health Incidents

## Interventions

- **DRUG:** Xeomin (incobotulinumtoxinA)

## Key facts

- **NCT ID:** NCT07267819
- **Lead sponsor:** Uniformed Services University of the Health Sciences
- **Sponsor class:** FED
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-05
- **Primary completion:** 2028-06-06
- **Final completion:** 2028-06-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07267819

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07267819, "Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07267819. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*